I'm sorry I had you confused with Dr. Ron Garren publisher of the InvestBio newsletter. As for AVN, my buddies like the product pipeline, but not the management. They have taken positions in the company in the low $1 range. Your recommendation is the manin reason I'm still holding as I was ready to bail when they announced the RS. I hope you're right.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.